Latest debt-to-equity ratio
Recursion Pharmaceuticals Debt-to-equity ratio
Direct answer
Recursion Pharmaceuticals's debt-to-equity ratio is 7.28%.
The verified market snapshot reports 7.28%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Recursion Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 7.28%
Explore related company data
View Recursion Pharmaceuticals's market capitalizationView Recursion Pharmaceuticals's price-to-book ratioView Recursion Pharmaceuticals's return on equityView Recursion Pharmaceuticals's dividend yieldView Recursion Pharmaceuticals's 52-week price rangeView Recursion Pharmaceuticals's revenue growthView Recursion Pharmaceuticals's profit marginView all Recursion Pharmaceuticals key metricsReturn to Recursion Pharmaceuticals profile